『Global Medical Device Podcast powered by Greenlight Guru』のカバーアート

Global Medical Device Podcast powered by Greenlight Guru

Global Medical Device Podcast powered by Greenlight Guru

著者： Greenlight Guru + Medical Device Entrepreneurs
無料で聴く

The Global Medical Device Podcast, powered by Greenlight Guru, is where today's brightest minds in the medical device industry go to get their most useful and actionable insider knowledge, direct from some of the world's leading medical device experts and companies.Greenlight Guru 経済学 衛生・健康的な生活 身体的病い・疾患
エピソード
  • #462: Implementing an eQMS: The Ultimate Move-In Guide for MedTech Leaders

    #462: Implementing an eQMS: The Ultimate Move-In Guide for MedTech Leaders
    2026/06/29
    In this episode, host Etienne Nichols sits down with Michaela Kivett, a seasoned medical device consultant at Greenlight Guru, to break down the complexities of implementing an electronic Quality Management System (eQMS). Drawing from her background in orthopedic implant contract manufacturing and pharmaceutical process engineering, Michaela shares firsthand accounts of the critical inefficiencies that plague traditional paper and generic electronic repositories like SharePoint or Google Drive.The conversation centers around the strategic planning required to transition between quality management states. Michaela introduces a powerful moving house analogy, illustrating that simply dragging and dropping messy, legacy records into a new digital environment will not solve underlying organizational issues. Instead, a successful migration requires an intentional internal self-evaluation, a culture of quality, and a structured, room-by-room approach to data and process transfer.Additionally, the episode highlights how forward-thinking MedTech companies are leveraging advanced tools, including artificial intelligence, to streamline their eQMS implementation. By using AI to scan documents for compliance deficiencies against standards like ISO 13485, categorize sprawling folders, and map out workflow updates, manufacturers can dramatically mitigate the transitional efficiency dip and establish a mature, robust foundation for future scale.Key Timestamps00:42 – Michaela Kivett’s background: Transitioning from orthopedic quality engineering to pharma process engineering, and finding a passion for MedTech consulting.03:15 – Operational friction: Real-world pain points of on-site communication, tracking down physical signatures across 100-acre facilities, and booking conference rooms.04:32 – Version control nightmares: The consequences of multiple departments making parallel redlines without localized system notifications.06:12 – Defining the eQMS: Distinguishing between a basic electronic file repository (SharePoint/Google Drive) and a specialized, medical device-focused quality platform.08:58 – The universal MedTech pain point: Systemic organizational complexity and the hidden administrative burden of manual document referencing.10:43 – The Rube Goldberg illustration: How disconnected spreadsheets, Word files, and manual trackers create fragile operational systems.13:02 – The three legs of the medical device stool: Balancing ethical, legal, and monetary drivers to build organizational maturity.16:04 – The "moving house" migration framework: Why dragging and dropping cluttered records fails and how to evaluate a legacy data landscape before a move.19:25 – Operational entropy: Managing legacy supplier history and updating training matrices during a system overhaul.21:10 – Leveraging AI in eQMS implementation: Using automated tools to scan documents for ISO 13485 gaps and auto-categorize large file volumes.Quotes"Organization is the most common pain point. And it's a very simple pain point. I think every industry probably feels that... but you underestimate exactly how many different documents and records you're going to be producing and how many different places they tie into each other." — Michaela KivettTakeawaysAudit Before You Migrate: Treat an eQMS implementation as an internal audit. Do not lift and shift messy legacy files; instead, use the transition to purge obsolete records and refine active procedures.Mitigate the Efficiency Dip: Anticipate a temporary slowdown during a software transition. Minimize this area under the curve by building a sequential plan that prioritizes core procedures and training matrices before migrating complex design or risk data.Design for Future Scale: Choose and configure your digital quality architecture not just for the team you have today, but for the corporate milestones of tomorrow—whether that involves clinical trials, an international 510(k) submission, or M&A.Deploy AI for Compliance Mapping: Utilize AI tools to systematically scan old documentation folders for standard gaps (such as ISO 13485 or ISO 14971 compliance) and to automate the heavy lifting of categorizing thousands of uncategorized records.ReferencesISO 13485: The international standard outlining quality management system requirements specific to the medical device industry.Greenlight Guru: Purpose-built medical device software platform offering specialized QMS and EDC solutions to accelerate commercialization and ensure lifecycle compliance.Connect with the host, Etienne Nichols on LinkedIn.MedTech 101 SectionWhat is the difference between a QMS and an eQMS?Think of your QMS (Quality Management System) as the blueprint for an entire house. It represents the actual words, rules, regulations, and standard operating procedures (SOPs) that dictate how your company builds safe medical hardware.The eQMS (electronic Quality Management System) is the physical structure and construction ...
    続きを読む 一部表示
    39 分
  • #463: Finding MedTechs Leading Voices with Sean Smith

    #463: Finding MedTechs Leading Voices with Sean Smith
    2026/07/06
    The medical device industry functions as a highly complex ecosystem where diverse niches—including regulatory affairs, quality assurance, marketing, and reimbursement—must seamlessly interconnect to bring life-saving technologies to life. In this episode, host Etienne Nichols sits down with Sean Smith, a 25-year B2B marketing veteran, journalist, and founder of the weekly LinkedIn newsletter MedTech Leading Voices. Together, they peel back the curtain on why traditional, corporate-centric marketing strategies often fail within the specialized medical device space, exploring instead how service providers, consultants, and experts can effectively communicate their value without losing their human touch.As generative AI tools begin to saturate digital platforms with automated content, the landscape of B2B marketing has grown increasingly crowded and noisy. Sean discusses the critical paradigm shift required to cut through this digital "slop," emphasizing that true marketing success is rooted in foundational human behavior rather than algorithm hacking or perfect websites. He challenges the standard corporate playbook, pointing out the futility of over-polished taglines and unread online case studies, and explains how authentic storytelling and real-world problem-solving serve as the primary mechanisms for earning industry trust.Looking toward the future of professional expertise, the conversation addresses the long-game nature of organic visibility and the rising importance of specialized professional networks. Sean outlines actionable strategies for medical device experts to transition their buried, day-to-day insights into public thought leadership by focusing on what truly drives human behavior: helping peers make money or keeping them out of trouble. Ultimately, the episode serves as a powerful reminder that robust, human-centric communities are the ultimate safeguard for safeguarding one's livelihood and career longevity in an automated world.Key Timestamps00:05 – Introduction of guest Sean Smith and the interconnected MedTech ecosystem.01:52 – The origin story of MedTech Leading Voices and the challenges of navigating LinkedIn's closed platform.03:11 – How the B2B marketing landscape has changed since 2022 with the rise of AI-generated content.04:15 – Core philosophical pillars of modern marketing: Being human first and showing genuine interest in others.06:22 – Debunking the B2C vs. B2B crossover myth and the trap of corporate website redesigns.07:54 – How MedTech experts can unlock hidden value by documenting their day-to-day problem-solving.09:41 – Repackaging technical content (webinars, articles, infographics) for different audience attention spans.11:15 – The ultimate human motivators in professional spaces: Making money and staying out of trouble.12:55 – Journalism principles in marketing: The critical value of expert attribution over anonymous AI output.14:38 – Tactful visibility tricks for LinkedIn and the hidden power of a postscript (P.S.) in email communications.15:52 – Etienne's "accidental" conference moderation strategy for gaining immediate executive access.17:15 – Tactical advice for vendors: Building advisory boards and dropping the constant hard pitch.18:50 – Leveraging free platforms like Substack to establish niche authority through consistency.21:04 – Redefining "community" as an existential shield against automated AI displacement.22:20 – Benchmarking success on social platforms: Shifting from vanity metrics to aggregate long-term trends.23:45 – Case Study: How focusing on a niche topic like CAPA can generate a massive, passionate industry following.Quotes"First be human. First be a human being... I think that it's very difficult to humanize the kind of in-depth regulatory, quality, risk discussions that we have... and so we're trying to make this information accessible, understandable, and keep it at a human scale." - Sean Smith"The European audience wants the same thing that everybody wants. They want to know how to make more money and how to stay out of trouble. Those are the only two things that motivate human beings. So if you can tether the story that you're telling to one of those two things... people don't like making mistakes." - Sean SmithTakeawaysRegulatory & Quality AssuranceCommoditization of "How-To" Content: Baseline regulatory explanations (e.g., standard steps to file a 510(k)) are rapidly becoming digitized and automated by LLMs. True value lies in sharing your unique perspective, industry misconceptions, and nuanced edge cases rather than boilerplate text.Medical Device R&DDocument the Daily Defenses: Engineers and developers provide value continuously through emails, internal PowerPoint presentations, and custom proposals. Capture these unique problem-solving workflows systematically to build a library of narrative proof points.Marketing & SalesDrop the Pitch-Slap: Avoid aggressive, transactional sales messaging on ...
    続きを読む 一部表示
    45 分
  • #465: Why Good Medical Devices Fail: Reimbursement Strategy with Ali Samiian

    #465: Why Good Medical Devices Fail: Reimbursement Strategy with Ali Samiian
    2026/07/20
    In this episode, host Etienne Nichols sits down with Ali Samiian, founder and managing principal of Popular Access Advisors, to demystify the critical and often misunderstood world of MedTech reimbursement. Far too many early-stage medical device companies treat reimbursement as a secondary, post-launch paperwork exercise, only to find that their brilliant, FDA-cleared technology fails because no one has figured out who will pay for it. Ali draws on his 20-plus years of experience in market access, health economics, and executive leadership to explain why reimbursement must be treated as a core product strategy long before submission.The conversation explores how commercialization pathways are inherently dictated by the site of care—whether inpatient, outpatient, or home use. Ali highlights common and costly pitfalls, such as designing clinical trials solely for FDA clearance while neglecting the specific evidence endpoints that insurance payers demand. Payers do not just look at safety and efficacy; they look at long-term clinical value, accessibility, durability, and standard-of-care comparisons. Using practical, real-world examples, Ali demonstrates how simple adjustments to product design and clinical study lengths can proactively align a device with existing or novel code requirements.Finally, the episode highlights the shifting regulatory landscape and new initiatives designed to accelerate market access for breakthrough innovations. Etienne and Ali discuss the FDA’s Total Lifecycle Product Advisory (TAP) program and the emerging CMS Regulatory Alignment for Predictable and Immediate Device (RAPID) program. By understanding these frameworks and embedding payer-relevant outcomes into early-stage research, innovators can significantly compress their revenue cycles, avoid product redesigns, and successfully deliver life-changing technologies into the hands of patients.Key Timestamps00:03 - Introduction to MedTech reimbursement and guest Ali Samiian.01:46 - The difference between clearing the FDA bar and achieving commercial success.02:16 - Case Study: How product design and classification categories impact commercialization.03:45 - The risk of ignoring durable medical equipment (DME) requirements during design.05:22 - Categorizing sites of care: Inpatient, outpatient, ASCs, and home use (DMEPOS).06:15 - Mistake #1: Postponing reimbursement strategy until after FDA approval.07:35 - Mistake #2: Designing clinical studies for the FDA without considering payer-relevant endpoints.09:02 - Understanding standard of care, durability data, and minimizing study bias for payers.10:30 - Exploring the FDA's TAP program and the new CMS RAPID program for breakthrough devices.12:15 - Mistake #3: Rushing regulatory pathways without assessing commercial and price-point implications.13:50 - Identifying stakeholders and understanding the oblique nature of CMS and payer regulations.14:38 - Deconstructing how to build new codes and establish premium pricing from scratch.Quotes"Clearing the FDA bar is not really what gets us to commercialization. We need to have product and clinical differentiation... A lot of reimbursement is actually more of a strategy exercise." - Ali Samiian"The FDA basically looks at is the product safe and effective? Payers look at is there value and is there accessibility for the product?" - Ali SamiianTakeawaysIncorporate Payer Endpoints Early: MedTech innovators should involve a reimbursement advisor during clinical trial design to incorporate payer-relevant endpoints (like durability and standard-of-care comparisons), avoiding the need for an expensive second study.Align Design with Code Descriptors: Ensure product features and testing durations match the strict regulatory definitions of your target site of care (e.g., verifying a home-use device meets the three-year durability testing threshold for DME classification).Evaluate Pathways Holistically: Assess regulatory pathways (510(k) vs. De Novo vs. PMA) not just by upfront cost or speed to market, but by their long-term implications on pricing, coding, and time-to-reimbursement.Leverage Breakthrough Programs: Companies with breakthrough device designation should actively follow and align with collaborative initiatives like the FDA's TAP and CMS's RAPID programs to secure immediate coverage upon clearance.ReferencesFDA TAP Program: The Total Lifecycle Product Advisory program designed to provide early, strategic communication with senior FDA leadership for breakthrough devices.CMS RAPID Program: Regulatory Alignment for Predictable and Immediate Device program, an initiative aimed at accelerating coverage pathways for breakthrough innovations.Etienne Nichols: Connect with the host on LinkedIn.MedTech 101 SectionReimbursement vs. FDA Clearance: Think of FDA clearance as getting a driver's license—it proves your device is safe to be on the road. Reimbursement is like getting a toll pass; it determines who is actually going to pay for the ...
    続きを読む 一部表示
    39 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません